• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道和胰腺内分泌肿瘤生物学要点

Highlights of the biology of endocrine tumours of the gut and pancreas.

作者信息

Rindi G, Bordi C

机构信息

Department of Pathology and Laboratory Medicine, University of Parma,Via Gramsci 14, I-43100 Parma, Italy.

出版信息

Endocr Relat Cancer. 2003 Dec;10(4):427-36. doi: 10.1677/erc.0.0100427.

DOI:10.1677/erc.0.0100427
PMID:14713255
Abstract

Originating from cells of the diffuse endocrine system the endocrine tumours of the gut and the pancreatic tract are rare entities characterized by a common phenotypic aspect and producing several bioactive substances including growth factors. Two major categories are identified: well-differentiated and poorly differentiated tumours. The clinical behaviour varies ranging from benign to low grade malignant for well-differentiated tumours/carcinomas to high grade malignant for poorly differentiated carcinomas. The two major categories of well-differentiated and poorly differentiated tumours display distinct phenotypes and genetic backgrounds possibly supporting distinct histogenesis. Genetic abnormalities associated with either induction or progression of tumours may vary depending on the site of origin.

摘要

起源于弥漫性内分泌系统细胞的胃肠道和胰腺内分泌肿瘤是罕见的实体,其特征在于具有共同的表型特征,并产生包括生长因子在内的多种生物活性物质。可分为两大类:高分化肿瘤和低分化肿瘤。临床行为各不相同,高分化肿瘤/癌从良性到低度恶性,低分化癌则为高度恶性。高分化和低分化肿瘤这两大类表现出不同的表型和遗传背景,这可能支持不同的组织发生学。与肿瘤诱导或进展相关的基因异常可能因起源部位而异。

相似文献

1
Highlights of the biology of endocrine tumours of the gut and pancreas.肠道和胰腺内分泌肿瘤生物学要点
Endocr Relat Cancer. 2003 Dec;10(4):427-36. doi: 10.1677/erc.0.0100427.
2
Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤的生物学和分子学方面
Digestion. 2000;62 Suppl 1:19-26. doi: 10.1159/000051851.
3
Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.胃肠道内分泌肿瘤:病因、分子发病机制与遗传学
Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):519-34. doi: 10.1016/j.bpg.2005.03.005.
4
NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.NESP55是一种新型嗜铬粒蛋白样肽,在胰腺和肾上腺髓质的内分泌肿瘤中表达,但在回肠类癌中不表达。
Br J Cancer. 2003 Jun 2;88(11):1746-54. doi: 10.1038/sj.bjc.6600924.
5
Endocrine tumors of the gut and pancreas tumor biology and classification.肠道和胰腺内分泌肿瘤:肿瘤生物学与分类
Neuroendocrinology. 2004;80 Suppl 1:12-5. doi: 10.1159/000080733.
6
Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.胰腺和胃肠道内分泌肿瘤的分子学方面
Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S135-8.
7
Tumour biology of gastroenteropancreatic neuroendocrine tumours.胃肠胰神经内分泌肿瘤的肿瘤生物学
Neuroendocrinology. 2004;80 Suppl 1:8-11. doi: 10.1159/000080732.
8
The phenotype of gut endocrine tumours.肠道内分泌肿瘤的表型。
Dig Liver Dis. 2004 Feb;36 Suppl 1:S26-30. doi: 10.1016/j.dld.2003.11.010.
9
Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.胃肠胰神经内分泌肿瘤疾病的分子与细胞生物学方面。会议论文集。德国柏林,1993年11月3日至7日。
Ann N Y Acad Sci. 1994 Sep 15;733:1-535.
10
Tumour biology and histopathology of neuroendocrine tumours.神经内分泌肿瘤的肿瘤生物学与组织病理学
Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):15-31. doi: 10.1016/j.beem.2007.01.004.

引用本文的文献

1
Synchronous Insulinoma and Glucagonoma: A Review of the Literature.同步胰岛素瘤和胰高血糖素瘤:文献复习。
In Vivo. 2023 Nov-Dec;37(6):2402-2408. doi: 10.21873/invivo.13345.
2
Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy.雌激素诱导基因和雌激素受体β在胰腺神经内分泌肿瘤中的表达:对靶向治疗的启示。
Pancreas. 2014 Oct;43(7):996-1002. doi: 10.1097/MPA.0000000000000203.
3
Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.胰腺神经内分泌肿瘤:生物学、诊断与治疗
Chin J Cancer. 2013 Jun;32(6):312-24. doi: 10.5732/cjc.012.10295. Epub 2012 Dec 14.
4
Pathologic pancreatic endocrine cell hyperplasia.胰腺内分泌细胞增生性病变。
World J Gastroenterol. 2011 Jan 14;17(2):137-43. doi: 10.3748/wjg.v17.i2.137.
5
IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).白细胞介素-2 -330T/G 单核苷酸多态性与血清水平-胃肠道和胰腺神经内分泌肿瘤(GEP-NETs)的潜在新肿瘤标志物。
J Mol Med (Berl). 2010 Apr;88(4):423-9. doi: 10.1007/s00109-009-0581-x. Epub 2010 Jan 5.
6
Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior.胃肠道和胰腺内分泌肿瘤:分级、肿瘤大小和增殖指数不能预测恶性行为。
Diagn Pathol. 2007 Aug 8;2:28. doi: 10.1186/1746-1596-2-28.
7
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.世界卫生组织分类、尿5-羟吲哚乙酸及肝功能检查在胃肠道胰腺转移性神经内分泌癌中的预后作用
Br J Cancer. 2007 Apr 23;96(8):1178-82. doi: 10.1038/sj.bjc.6603699. Epub 2007 Apr 3.
8
Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy.神经内分泌肿瘤的肝转移;早期降低肿瘤负荷以提高预期寿命。
World J Surg Oncol. 2006 Jun 26;4:35. doi: 10.1186/1477-7819-4-35.